Search research articles
Contact Us
Filters
Showing results (191-200 of 271) with videos related to
Page
of 28
Sort By:
Leukemia
|
March 5, 2010
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
M Jenal, J Batliner, V A Reddy, et al.
The Journal of Clinical Investigation
|
May 1, 1992
Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe
M F Fey, H J Peter, H L Hinds, et al.
Journal of the National Cancer Institute
|
September 24, 1999
Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells
U Hasse, M Tinguely, E O Leibundgut, et al.
British Journal of Haematology
|
December 8, 2011
Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells
Jasmin Batliner, Emanuel Buehrer, Elena A Federzoni, et al.
European Journal of Haematology
|
October 24, 1997
Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK)
A Lohri, B van Hille, M Bacchi, et al.
Blood
|
April 14, 2012
PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells
Elena A Federzoni, Peter J M Valk, Bruce E Torbett, et al.
Oncogene
|
June 4, 2008
DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function
A Britschgi, E Trinh, M Rizzi, et al.
Cancer Research
|
September 15, 1999
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis
U R Peters, M P Tschan, K A Kreuzer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.
British Journal of Haematology
|
September 1, 1993
Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia
F Joncourt, A Oberli, S M Redmond, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 271) with videos related to
Sort By:
Page
of 28
Leukemia
|
March 5, 2010
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
M Jenal, J Batliner, V A Reddy, et al.
The Journal of Clinical Investigation
|
May 1, 1992
Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe
M F Fey, H J Peter, H L Hinds, et al.
Journal of the National Cancer Institute
|
September 24, 1999
Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells
U Hasse, M Tinguely, E O Leibundgut, et al.
British Journal of Haematology
|
December 8, 2011
Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells
Jasmin Batliner, Emanuel Buehrer, Elena A Federzoni, et al.
European Journal of Haematology
|
October 24, 1997
Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK)
A Lohri, B van Hille, M Bacchi, et al.
Blood
|
April 14, 2012
PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells
Elena A Federzoni, Peter J M Valk, Bruce E Torbett, et al.
Oncogene
|
June 4, 2008
DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function
A Britschgi, E Trinh, M Rizzi, et al.
Cancer Research
|
September 15, 1999
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis
U R Peters, M P Tschan, K A Kreuzer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.
British Journal of Haematology
|
September 1, 1993
Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia
F Joncourt, A Oberli, S M Redmond, et al.
Page
of 28